Entity Details

Primary name IDHP_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP48735
EntryNameIDHP_HUMAN
FullNameIsocitrate dehydrogenase [NADP], mitochondrial
TaxID9606
Evidenceevidence at protein level
Length452
SequenceStatuscomplete
DateCreated1996-02-01
DateModified2021-06-02

Ontological Relatives

GenesIDH2

GO terms

Show/Hide Table
GOName
GO:0000287 magnesium ion binding
GO:0004450 isocitrate dehydrogenase (NADP+) activity
GO:0005739 mitochondrion
GO:0005759 mitochondrial matrix
GO:0005777 peroxisome
GO:0005829 cytosol
GO:0005975 carbohydrate metabolic process
GO:0006097 glyoxylate cycle
GO:0006099 tricarboxylic acid cycle
GO:0006102 isocitrate metabolic process
GO:0006103 2-oxoglutarate metabolic process
GO:0006739 NADP metabolic process
GO:0006741 NADP biosynthetic process
GO:0051287 NAD binding
GO:0060253 negative regulation of glial cell proliferation
GO:0070062 extracellular exosome
GO:1903976 negative regulation of glial cell migration
GO:1904465 negative regulation of matrix metallopeptidase secretion

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion

Domains

Show/Hide Table
DomainNameCategoryType
IPR004790 Isocitrate dehydrogenase NADP-dependentFamilyFamily
IPR019818 Isocitrate/isopropylmalate dehydrogenase, conserved siteSiteConserved site
IPR024084 Isopropylmalate dehydrogenase-like domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613657 OMIMD-2-hydroxyglutaric aciduria 2 (D2HGA2)A neurometabolic disorder causing developmental delay, epilepsy, hypotonia, and dysmorphic features. Both a mild and a severe phenotype exist. The severe phenotype is homogeneous and is characterized by early infantile-onset epileptic encephalopathy and cardiomyopathy. The mild phenotype has a more variable clinical presentation. Diagnosis is based on the presence of an excess of D-2-hydroxyglutaric acid in the urine. The disease is caused by variants affecting the gene represented in this entry.
137800 OMIMGlioma (GLM)Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. The gene represented in this entry is involved in disease pathogenesis.

Drugs

Show/Hide Table
DrugNameSourceType
DB01727 Isocitric AcidDrugbanksmall molecule
DB13874 EnasidenibDrugbanksmall molecule